2011
DOI: 10.1002/jhm.872
|View full text |Cite
|
Sign up to set email alerts
|

Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood

Abstract: OBJECTIVE: To determine the comparative effectiveness of common pleural drainage procedures for treatment of pneumonia complicated by parapneumonic effusion (ie, complicated pneumonia). DESIGN: Multicenter retrospective cohort study. SETTING: Forty children's hospitals contributing data to the Pediatric Health Information System. PARTICIPANTS: Children with complicated pneumonia requiring pleural drainage. MAIN EXPOSURES: Initial drainage procedures were categorized as chest tube without fibrinolysis, chest tu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
24
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(24 citation statements)
references
References 41 publications
0
24
0
Order By: Relevance
“…The adjusted costs of patient visits were calculated. In order to calculate adjusted costs, the actual charges recorded in PHIS were adjusted by the United States’ Centers for Medicare and Medicaid price/wage index for each hospital location and hospital-level cost-to-charge ratios 14 15…”
Section: Methodsmentioning
confidence: 99%
“…The adjusted costs of patient visits were calculated. In order to calculate adjusted costs, the actual charges recorded in PHIS were adjusted by the United States’ Centers for Medicare and Medicaid price/wage index for each hospital location and hospital-level cost-to-charge ratios 14 15…”
Section: Methodsmentioning
confidence: 99%
“…Hospitalizations for parapneumonic empyema were identified as any pneumonia hospitalization with a diagnosis of empyema (primary or otherwise). A separate analysis was conducted to assess a more specific outcome measure using only hospitalizations for parapneumonic empyema with a documented thoracentesis-related procedure for the diagnosis or management of empyema, including video-assisted thorascopic surgery (ICD9-CM: 34.04, 34.06, 34.09, 34.21, 34.51, 34.52, and 34.91) [23]. In addition, discharge diagnosis codes were used to classify hospitalizations for parapneumonic empyema based on the likely causative organism into mutually exclusive groups and according to the following hierarchy: pneumococcal (ICD9-CM: 481), streptococcal (ICD9-CM: 482.3, 041.0, 038.0), staphylococcal (ICD9-CM: 482.4, 041.1, 038.1) or unspecified (other/unknown etiology).…”
Section: Hospitalizations For Parapneumonic Empyemamentioning
confidence: 99%
“…In addition, discharge diagnosis codes were used to classify hospitalizations for parapneumonic empyema based on the likely causative organism into mutually exclusive groups and according to the following hierarchy: pneumococcal (ICD9-CM: 481), streptococcal (ICD9-CM: 482.3, 041.0, 038.0), staphylococcal (ICD9-CM: 482.4, 041.1, 038.1) or unspecified (other/unknown etiology). The ICD9-CM codes to identify hospitalizations for pneumonia have been validated in prior studies, and the strategy to identify hospitalizations for parapneumonic empyema, including by likely causative organism, have been reported previously [7,8,[23][24][25].…”
Section: Hospitalizations For Parapneumonic Empyemamentioning
confidence: 99%
“…Adjusted billed charges are the billed charges adjusted by the US Centers of Medicare and Medicaid Services' price/ wage index for the study site's location. 32,33 To compare albuterol of different delivery methods, albuterol equivalents were calculated. Based upon prior research demonstrating equal efficacy between albuterol administered by nebulizer and metered-dose inhaler (MDI), 34 every 2.5 mg of albuterol administered by nebulizer was treated as equivalent to 2 sprays of albuterol (90 mg/spray) administered by MDI.…”
Section: Study Setting and Participantsmentioning
confidence: 99%